drugset / Trial / NCT00261482

Evaluation of Women's Experience With EVRA (Norelgestromin + Ethinyl Estradiol) Transdermal Contraceptive Patch Compared With Previous Methods of Contraception.

NCT00261482

Phase 4 Completed 778 enrolled Janssen Pharmaceutica N.V., Belgium
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to evaluate user experience with the EVRA® Contraceptive Transdermal Patch; specifically, user satisfaction with the EVRA® Patch, and if applicable, user preference of the EVRA® Patch compared with the previous method of contraception. The study also evaluates contraceptive efficacy, safety and user compliance.

Timeline

Start
2003-07
Primary completion
Completion
2004-12

Drugs

EvaluationDrugModalityDoseRoute
Subject ethinyl estradiol Small molecule 20 ug Other
Subject norelgestromin Unknown 150 ug Other

Indications

No indication recorded.